Home > Insider Trading > Filing (0001181431-11-010501)

Filing Details

Accession Number:: 0001181431-11-010501
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-02-15 17:39:37
Reporting Period:: 2011-02-14

Filing Date:: 2011-02-15
Accepted Time:: 2011-02-15 17:39:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1392380	Gevo Inc.	GEVO	Industrial Organic Chemicals (2860)	870747704

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1083218	Ganesh Kishore	No. 36-01, Level Menara Dion 27, Jalan Sultan Ismail 50250 Kuala Lumpur N8		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-02-14	1,540,739	$0.00	1,540,739	No	4	C	Indirect	By fund
Common Stock	Acquisiton	2011-02-14	130,686	$15.00	1,671,425	No	4	P	Indirect	By fund

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By fund
No	4	P	Indirect	By fund

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series C Preferred Stock	Disposition	2011-02-14	802,920	$0.00	802,920	$0.00
Common Stock	Series D Preferred Stock	Disposition	2011-02-14	497,160	$0.00	497,160	$0.00
Common Stock	Series D-1 Preferred Stock	Disposition	2011-02-14	126,515	$0.00	240,659	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Represents the aggregate number of shares of common stock deemed to be beneficially owned by the reporting person following conversion of the shares of preferred stock previously deemed to be beneficially owned by the reporting person and reflected in Table II of this Form 4.
Upon completion of the Issuer's initial public offering of common stock, all shares of preferred stock deemed to be beneficially owned by the reporting person, other than shares of Series D-1 Preferred Stock, were automatically converted into shares of the Issuer's common stock on a one-for-one basis and had no expiration date.
Upon completion of the Issuer's initial public offering and in accordance with the terms of the Issuer's Amended and Restated Certificate of Incorporation, filed with the Secretary of State of the State of Delaware on May 4, 2010, a copy of which is attached as Exhibit 3.1 to the Issuer's Registration Statement on Form S-1 (File No. 333-168792), as amended, initially filed with the Securities and Exchange Commission on August 12, 2010, the Series D-1 Preferred Stock was automatically converted into shares of the Issuer's common stock at a ratio of 1:1.90222 and had no expiration date.
The securities were issued to Malaysian Life Sciences Capital Fund Ltd. ("Malaysian Life Sciences"). Ganesh Kishore, Ph.D. is the Chief Executive Officer of Malaysian Life Sciences and may be held to have voting and dispositive power over shares held by the fund. Dr. Kishore disclaims beneficial ownership of shares held by Malaysian Life Sciences except to the extent of his pecuniary interest therein.